ArticleCancer research2024

Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer.

Mustafa Emre Gedik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.